UAE Surgical Suture Market, By Type (Automated Suturing Device, Suture Thread), By Application (Cardiovascular Surgery, General Surgery, Gynaecological Surgery, Orthopedic Surgery, Ophthalmic Surgery), By End User (Hospitals & Clinics, Ambulatory Care Centres, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 67.89 Million
CAGR (2026-2031)	8.11%
Fastest Growing Segment	Automated Suturing Device
Largest Market	Dubai
Market Size (2031)	USD 108.39 Million

Market Overview

The UAE Surgical Suture Market will grow from USD 67.89 Million in 2025 to USD 108.39 Million by 2031 at a 8.11% CAGR. Surgical sutures are medical devices comprising a needle with an attached thread, used to approximate and hold body tissues together following injury or surgical procedures, thereby facilitating proper wound healing. The UAE Surgical Suture Market's growth is primarily driven by the increasing volume of surgical procedures across diverse medical specialties, an expanding aging population, and the rising prevalence of chronic diseases necessitating operative interventions. Furthermore, substantial government investments in healthcare infrastructure development and enhanced access to advanced medical technologies consistently contribute to market expansion.

A notable challenge inhibiting market growth is the complex regulatory environment, which involves stringent approval processes and potential delays for the introduction of new medical devices. However, according to the Dubai Health Authority, in 2025, the number of licensed healthcare facilities in Dubai increased to approximately 5,800, and the private healthcare workforce grew by over 8 percent, exceeding 69,400 professionals, indicating a robust expansion in surgical capacity.

Key Market Drivers

Rising surgical volumes driven by disease burden, aging population, and medical tourism.
The increasing volume of surgical procedures significantly drives the UAE Surgical Suture Market. This growth is fueled by a rising burden of chronic diseases, a growing geriatric population requiring various surgical interventions, and an expanding healthcare ecosystem catering to both residents and international patients. The robust medical tourism sector, in particular, contributes substantially to this demand. According to the Dubai Health Authority, as reported by ITIJ in August 2024, Dubai welcomed 691,000 medical tourists in 2023, reflecting a year-on-year rise in individuals seeking medical treatment, many of whom undergo surgical procedures. Such an upsurge in surgical cases directly translates into a higher consumption of surgical sutures across diverse medical specialties.

Public investment and infrastructure expansion bolster healthcare capacity and sutures demand.
Complementing this trend are substantial government healthcare investments and infrastructure development initiatives across the UAE. These strategic investments aim to enhance the country's medical capacity, modernize facilities, and improve access to advanced healthcare services. For instance, according to the Health Accounts System of Dubai 2024 report, the majority of current healthcare expenditure in 2024 was directed to hospitals, totaling AED 11,211 million, demonstrating a clear focus on bolstering core medical infrastructure. This continuous expansion of healthcare facilities and services creates an environment conducive to performing more surgical procedures, thereby sustaining the demand for surgical sutures. Overall, according to the Health Accounts System of Dubai 2024 report by the Dubai Health Authority, total healthcare spending in Dubai reached approximately Dh24.55 billion in 2024, underscoring the significant economic activity within the sector.

Download Free Sample Report

Key Market Challenges

Regulatory Hurdles Impede Market Entry and Diversification
The complex regulatory environment, characterized by stringent approval processes and potential delays for new medical device introductions, significantly impedes the expansion of the UAE Surgical Suture Market. This intricate landscape necessitates considerable time and resource allocation for manufacturers, particularly those seeking to introduce advanced suture technologies. The prolonged registration periods and the rigorous documentation requirements increase the operational burden and financial outlay, making market entry and product diversification more challenging for both established and new entrants.

Regulatory Complexity Drives Market Concentration
Furthermore, this regulatory complexity contributes to a concentrated market structure, limiting competition and potentially slowing innovation. According to analysis of Emirates Drug Establishment data by MedDeviceGuide, in June 2026, ten suppliers collectively controlled 33.7 percent of the 4,793 active medical device registrations in the UAE, indicating a consolidated landscape. Such concentration suggests that the demanding regulatory pathway acts as a substantial barrier, restricting the introduction of a wider array of surgical sutures and thus directly hampering overall market growth by limiting choice and competitive pressure.

Key Market Trends

Impact of Minimally Invasive and Robotic Surgery on UAE Suture Demand
The growing preference for minimally invasive surgical techniques significantly shapes the UAE Surgical Suture Market. These techniques, including robotic-assisted procedures, reduce patient trauma, lessen recovery times, and require specialized sutures with finer gauges and enhanced precision. This shift drives demand for advanced suture materials and delivery systems. According to Gulf News, January 2025, in the 'Arab Health 2025: Why robot-assisted surgeries are rising in UAE' report, Cleveland Clinic Abu Dhabi performed over 400 robotic surgical cases in 2024, indicating a clear embrace of these advanced surgical methods.

Advances in Biodegradable and Smart Sutures
Concurrent with procedural advancements, the market is profoundly influenced by ongoing innovations in biodegradable and smart suture materials. These advancements focus on sutures offering controlled absorption rates, improved biocompatibility, and antimicrobial properties to reduce infection risk and promote optimal wound healing. Such materials enhance patient safety and comfort by negating the need for suture removal. According to KBR, February 2026, in the 'Samyang Biopharm showcases sutures, hemostatic agents at WHX Dubai 2026' article, Samyang Biopharm exhibited its advanced barbed suture, Therafix, at the World Health Expo in Dubai, and plans to expand its annual production capacity to 110,000 kilometers for such advanced suture technologies.

Segmental Insights

Rapid Growth of Automated Suturing Devices in the UAE Fueled by Precision, Efficiency, and Minimally Invasive Surgery
The Automated Suturing Device segment is experiencing the most rapid growth within the UAE Surgical Suture Market. This acceleration is primarily driven by the increasing demand for enhanced surgical precision and efficiency across various procedures. Automated devices offer significant advantages by reducing surgical time and improving the accuracy of tissue approximation, which directly contributes to better patient outcomes. Furthermore, the growing adoption of minimally invasive surgical techniques in the UAE healthcare system necessitates sophisticated suturing solutions that automated devices provide. The continuous integration of advanced medical technologies within the nation's evolving healthcare infrastructure also supports the increased preference for these innovative tools.

Regional Insights

Dubai as a Regional Healthcare Hub and Market Enabler
Dubai stands as a key regional insight in the UAE Surgical Suture Market, reflecting its overarching significance as a major healthcare hub. The emirate's dominance in this sector is driven by its strategic geographical location and well-developed medical infrastructure, attracting substantial investment in healthcare. Furthermore, Dubai's thriving medical tourism industry significantly boosts the demand for advanced surgical consumables, including sutures. The regulatory environment, managed by entities such as the Ministry of Health and Prevention (MOHAP) and the Dubai Health Authority (DHA), provides a clear framework that fosters market entry and growth for medical device companies. These combined factors create a robust ecosystem supporting the surgical suture market.

Recent Developments

• In January 2025, Unisur Lifecare, a global manufacturer and supplier of surgical equipment, unveiled new medical product launches at Arab Health in Dubai, UAE. The company's display at the event featured premium surgical sutures, among other offerings, designed to enhance patient safety and operational efficiency in surgical procedures. This introduction of an expanded range of surgical sutures underscores the company's commitment to advancing surgical solutions for the healthcare industry in the UAE.
• In January 2025, Auxein Medical introduced a comprehensive range of innovative orthopedic solutions at Arab Health in Dubai, UAE. This launch included specialized tools like the Reusable Suture Passer and the Knot Pusher with Suture Cutter, which are crucial for precise wound closure and tissue management. The new products were developed to streamline complex surgical procedures, reduce operative times, and improve patient safety, contributing to the advancements in surgical practices within the UAE surgical suture market.
• In February 2024, Auxein Medical, an orthopedic implant manufacturer and exporter, showcased its new arthroscopy product line at Arab Health in Dubai, UAE. This range included several advanced instruments directly impacting surgical suture procedures, such as a Gyrolock knotless screw-in anchor, a Knot Pusher with Suture Cutter for meniscal repair, and a Knotless Push-In Suture Anchor with Driver and Suture Passer. These innovations were presented to enhance surgical accuracy and improve patient care within the UAE surgical suture market.
• In January 2024, Surgexon, a manufacturer of advanced surgical solutions, announced its strategic collaboration with Platinum Medical, a regional partner, at Arab Health in Dubai. This partnership aimed to highlight cutting-edge technologies and contribute to advancements in healthcare excellence within the UAE. Surgexon's participation, alongside its partner, focused on showcasing their expertise in surgical solutions, including advanced sutures and surgical staplers, thereby strengthening their presence in the UAE surgical suture market through this collaborative effort.

Key Market Players

• Johnson & Johnson (Ethicon) UAE
• Medtronic UAE
• B. Braun Medical UAE
• Smith & Nephew UAE
• Boston Scientific UAE
• Stryker UAE
• Integra LifeSciences UAE
• Conmed UAE
• Teleflex UAE
• Peters Surgical UAE

By Type	By Application	By End User	By Region
Automated Suturing Device Suture Thread	Cardiovascular Surgery General Surgery Gynaecological Surgery Orthopedic Surgery Ophthalmic Surgery	Hospitals & Clinics Ambulatory Care Centres Others	Dubai Abu Dhabi Sharjah Rest of UAE

Report Scope:

In this report, the UAE Surgical Suture Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• UAE Surgical Suture Market, By Type:

• Automated Suturing Device
• Suture Thread

• UAE Surgical Suture Market, By Application:

• Cardiovascular Surgery
• General Surgery
• Gynaecological Surgery
• Orthopedic Surgery
• Ophthalmic Surgery

• UAE Surgical Suture Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centres
• Others

• UAE Surgical Suture Market, By Region:

• Dubai
• Abu Dhabi
• Sharjah
• Rest of UAE